MARK BURDT DO NPI 1245349182

NPI Details

Mark Burdt, DO is a rheumatology internal medicine in Urbandale, IA with 33 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Mark Burdt, DO NPI is 1245349182. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Graduation Year:1993

The provider's business location address is:

8421 PLUM DR
URBANDALE, IA
ZIP 50322-356
Phone: (515) 270-7222
Fax: (515) 270-7202

The NPI 1245349182 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Liver enzyme (sgot), level (HCPCS:84450)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Albumin (protein) level (HCPCS:82040)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Blood creatinine level (HCPCS:82565)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Calcium level, total (HCPCS:82310)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Vitamin d-3 level (HCPCS:82306)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Magnesium level (HCPCS:83735)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• X-ray of hand, 2 views (HCPCS:73120)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Uric acid level, blood (HCPCS:84550)
• Phosphate level (HCPCS:84100)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Rheumatoid factor level (HCPCS:86431)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• X-ray of pelvis, 1-2 views (HCPCS:72170)
• Ferritin (blood protein) level (HCPCS:82728)

The enumeration date for this NPI number is 8/30/2006 and was last updated on 5/13/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.